COMPANY PROFILE
| Price and Volume | |
|---|---|
| Recent Price | 33.11 |
| 52 Week High | 34.18 |
| 52 Week Low | 16.50 |
| Avg. Daily Vol. (Mil) | 0.07 |
| Beta (3 year) | 0.54 |
| Share Related Items | |
| Mkt Cap (Mil) | 491.42 |
| Shares Out (Mil) | 14.84 |
| Float (Mil) | 13.68 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 3.80 |
| Current Ratio | 6.60 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | 34.10 |
| Price/Sales | 4.02 |
| Price/Book | 3.64 |
| Price/Cash Flow | 26.60 |
| Per Share Data | |
| Earnings | 0.97 |
| Sales | 8.24 |
| Book Value | 9.09 |
| Cash Flow | 1.25 |
| Business Summary | |
|---|---|
| The Company and subsidiaries develop, manufacture, and market a diverse line of products dedicated to food and animal safety. | |
| General Information | |
| 620 Lesher Place
Lansing, MI 48912 |
|
| www.neogen.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 515 | |
| CEO: James L. Herbert | |
| Short Interest | |
| Current Month (Mil) | 1.00 |
| Previous Month (Mil) | 0.98 |
| Short Interest Ratio (Days) | 18.50 |
| Management Effectiveness | |
| Return on Equity | 10.80 |
| Return on Assets | 9.60 |
| Return on Investments | 10.80 |
| Profitability | |
| Gross Margin | 53.90 |
| EBIT Margin | 18.60 |
| Profit Margin | 11.90 |